Abstracts - faqs.org

Abstracts

Science and technology

Search abstracts:
Abstracts » Science and technology

Avoiding another Vioxx: Guarding against unsafe drugs means major changes

Article Abstract:

Vioxx, an inflammatory drug is found to double the risk of heart attack and stroke on long-term use, which led to its withdrawal. Food and Drug Administration (FDA) orders drug companies to conduct post marketing research as a condition of approval. The FDA program, which gathers reports of adverse effects voluntarily submitted by doctors, has garnered criticism from prominent medical journals and epidemiologists for its underreporting and unreliability.

Author: Beardsley, Sara
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2005
Complications and side effects, Inflammation, Inflammation mediators, Powers and duties, United States. Food and Drug Administration, Vioxx (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Doubt is their product

Article Abstract:

Industry groups sometimes manufacture uncertainty about solid scientific findings in order to fight off government regulation. Many companies that produce hazardous chemicals or drugs like phenylpropanolamine (PPA) and rofecoxib commonly known as Voxx have hired researchers to dispute and reanalyze data showing adverse health effects.

Author: Michaels, David
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2005
Product development, Science & research, Health aspects, Research, Hazardous substances

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Register or Perish

Article Abstract:

The article examines efforts to bring negative results of clinical trials to public attention. Discussion focuses on the launch of a journal targeting these results, and laws requiring pharmaceutical companies to report their results in a database accessible by the general public.

Author: Krakovsky, Marina
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2004
General services, Clinical trials, Company systems management, Information management, Medical publishing, Adverse drug reactions

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Laws, regulations and rules, Pharmaceutical industry, Government regulation
Similar abstracts:
  • Abstracts: Deserting the Sahara: Dying plants harvest harsh surprises from climate change. Looking for life below the bottom
  • Abstracts: Building the olivenhain. Making the transition. Study determines that restoring Hetch Hetchy Valley would be costly
  • Abstracts: Copper binding in the prion protein. Tyrosine-derived quinone cofactors. Loops, linkages, rings, catenanes, cages, and crowders: entropy-based strategies for stabilizing proteins
  • Abstracts: Crater jumper: Hopping probe may hunt for ice on the moon. Saving gas and lives. Fly me to the moon
  • Abstracts: Better ways to target pain. Experimental drugs on trial. Making drugs, not profits
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.